Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USITC Agreement to settle Dispute

From USITC 337-TA-853

B. Substance of the Agreement
The moving parties assert that the Agreement has been executed by the parties. See Mot.
Memo. at 1; see also Exh. at 15.

For the consideration set forth by the Agreement,

......PDS grants a license to Kyocera..... ,,

with respect to the sole asserted patent, U.S. Patent No. 5,809,336 (“the '336
patent”). Mot. Exh. at § 2.2. The Agreement thus appears to fully resolve the dispute between the moving parties


III. CONCLUSION
For the foregoing reasons, the joint motion to terminate this investigation with respect to
Kyocera should be granted.
Respectfully submitted,
/s/ R. Whitney Winston
Jeffrey T. Hsu, Acting Director
David O. Lloyd, Supervisory Attorney
R. Whitney Winston, Investigative Attorney
OFFICE OF UNFAIR IMPORT
INVESTIGATIONS

Now we see this much in PRINT...

Share
New Message
Please login to post a reply